Cargando…
Regulatory Considerations on the use of Machine Learning based tools in Clinical Trials
BACKGROUND: The widespread increasing use of machine learning (ML) based tools in clinical trials (CTs) impacts the activities of Regulatory Agencies (RAs) that evaluate the development of investigational medicinal products (IMPs) in clinical studies to be carried out through the use of data-driven...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638313/ https://www.ncbi.nlm.nih.gov/pubmed/36373014 http://dx.doi.org/10.1007/s12553-022-00708-0 |